TAKEDA PHARMA A/S: Financial statements 2021
CVR: 16406899
Source: annual report 2021, Danish Business Authority
01/04/2020 – 31/03/2021
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,939,231,000 and a net result of DKK 667,744,000 compared with DKK 2,661,113,000 the year before. That is an increase of 23.5% compared with the year before. The profit margin was 34.4%. Equity in the 2021 report amounted to DKK 1,046,401,000. The solvency ratio was 51.9%. The company had 174 employees in the financial year.
- Revenue
- DKK 1,939,231,000
- Gross Profit
- DKK 1,134,904,000
- Profit/Loss
- DKK 667,744,000
- Equity
- DKK 1,046,401,000
- Total Assets
- DKK 2,017,020,000
- Employees
- 174
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 1.9B | 1.1B | 667.7M | 1B | 174 |
| 2020 | 1.6B | 3.2B | 2.7B | 2.7B | 179 |
| 2019 | 1.6B | 562.3M | 84.7B | 1.3B | 177 |
| 2018 | 1.8B | 712.1M | 595.8M | 100.5B | 197 |
| 2017 | 1.7B | 626M | -102.6M | 99.9B | 305 |
Official annual report
Find more companies like TAKEDA PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 1, 2021, Roland Kurney is registered as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2021, Roland Kurney is registered as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2021, Roland Kurney has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of September 30, 2021, Lars Patrik Mikael Forsell has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of May 21, 2021, Christian Ramskov has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Gitte Hjelvang has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Duarte Joao Lourinho Marchand has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Niels Hansen has left the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Ingeborg Rossebø Borgheim has left the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Athinagoras Efthymios Giannoulis has left the board of directors of TAKEDA PHARMA A/S.
About TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.